Sort
46,585 grants matching “heart failure”
Activation of sirtuins to prevent adverse cardiac remodeling after CABG
$395,000Mahesh P Gupta · University Of Chicago · R01 · FY2016 · HL
Lymphatic Regulation of Skin Electrolyte Metabolism and Blood Pressure
$395,000Jens Marc Titze · Vanderbilt University Medical Center · R01 · FY2016 · HL
Regulation of the paracrine angiogenic function of cardiac myocytes by cardiomyoc
$395,000Wadih Arap · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · HL
The splenic CD4+ T cells mediate myocardial ischemia-reperfusion injury
$395,000Zequan Yang · University Of Virginia · R01 · FY2019 · HL
Signaling Mechanisms for Hypoxic Pulmonary Vasoconstriction
$395,000Yong-Xiao Wang · Albany Medical College · R01 · FY2012 · HL
Regulation of neurotransmitter properties by target-derived neurotrophic factors
$395,000Susan J Birren · Brandeis University · R01 · FY2010 · NS
Role of Gap Junction in Hypoxia-induced Pulmonary Hypertension
$395,000Ayako Makino · University Of California, San Diego · R01 · FY2022 · HL
Molecular mechanisms and treatment of cardiomyopathy in Barth Syndrome
$395,000Xi Fang · University Of California, San Diego · R01 · FY2024 · HL
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodeling
$395,000Joan Heller Brown · University Of California, San Diego · R01 · FY2022 · HL
Heart Failure in Cancer Patients
$395,000Hind Lal · Vanderbilt University Medical Center · R01 · FY2017 · HL
Genomic and Phenomic Architecture of Heart Failure
$395,000Quinn Stanton Wells · Vanderbilt University Medical Center · R01 · FY2022 · HL
Genomic and Phenomic Architecture of Heart Failure
$395,000Quinn Stanton Wells · Vanderbilt University Medical Center · R01 · FY2020 · HL
The Role of The T Cell In The Genesis of Hypertension
$395,000David G Harrison · Vanderbilt University Medical Center · R01 · FY2017 · HL
Calcium Handling in Cardiac Pathophysiology
$395,000Evangelia G Kranias · University Of Cincinnati · R01 · FY2017 · HL
Factor XI in Thrombosis
$395,000David Gailani · Vanderbilt University Medical Center · R01 · FY2017 · HL
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome
$395,000Charles C Hong · Vanderbilt University Medical Center · R01 · FY2018 · HL
The Cardiac Role of Filamin C
$395,000Ju Chen · University Of California, San Diego · R01 · FY2022 · HL
Signaling mechanisms governing myocardial fibrosis in diseased heart
$395,000Hind Lal · Vanderbilt University Medical Center · R01 · FY2017 · HL
The splenic CD4+ T cells mediate myocardial ischemia-reperfusion injury
$395,000Zequan Yang · University Of Virginia · R01 · FY2017 · HL
Novel pathways modulating Raf-mediated cardiac hypertrophy
$395,000Matthew J Wolf · University Of Virginia · R01 · FY2017 · HL
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies
$395,000Joseph C Wu · Stanford University · R01 · FY2019 · HL
Cell State Specific Modifiers of Pathological Cardiac Remodeling
$395,000Jason Becker · Vanderbilt University Medical Center · R01 · FY2017 · HL
Signaling mechanisms governing myocardial fibrosis in diseased heart
$395,000Hind Lal · Vanderbilt University Medical Center · R01 · FY2019 · HL
Elucidating Genotype-Phenotype Relationship of Congenital Cardiomyopathies
$395,000Joseph C Wu · Stanford University · R01 · FY2017 · HL
The Cardiac Role of Filamin C
$395,000Ju Chen · University Of California, San Diego · R01 · FY2021 · HL